John Maraganore, Ph.D.

John Maraganore, Ph.D.

DirectoratRapport Therapeutics· In proxies 2024–2025

John Maraganore, Ph.D. sits on 6 public boards.

Boards1

  • Rapport TherapeuticsDirector · 1 yr on the boardIndependentAudit, Compensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Rapport TherapeuticsPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role +8%
  2. Kymera Therapeutics, Inc.Public company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. Takeda Pharmaceutical Company LimitedPublic company · 4 yr
    • Director2022 – Present · 4 yrNo stock prices for these years
  4. Beam Therapeutics Inc.Public company · 5 yr
    • Director2021 – Present · 5 yrNo stock prices for these years
  5. ProKidney CorpPublic company · 2 yr
    • Director2022 – 2024 · 2 yrNo stock prices for these years
  6. Agios Pharmaceuticals, Inc.Public company · 13 yr
    • Director2010 – 2023 · 13 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?